Biomimetic Interface Device for Vascular Tissue Modeling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for modeling diseases and evaluating therapeutics in vitro are inadequate due to the inability to mimic in vivo physiological conditions, particularly in vascular systems, as they fail to replicate essential hemodynamic stresses and layered tissue architecture, leading to high failure rates of therapeutics in human trials.

Innovation Solution

A biomimetic apparatus featuring a spun elastomer scaffold within a cassette system with connected chambers and tubing, allowing for controlled fluid flow, pressure, and shear simulation, seeded with human cells to mimic vascular conditions and evaluate pharmacokinetics of therapeutics.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional static culture dishes are used for cell culture, then the device complexity is low and ease of manufacture is high, but the physiological relevance is insufficient because they cannot replicate hemodynamic stresses and layered tissue architecture

Engineering Contradiction:
Improvephysiological relevanceVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The device is divided into multiple cassettes, each containing a spun elastomer scaffold with seeded cells. This segmentation allows independent configuration of different tissue layers and hemodynamic conditions in each cassette, enabling physiological relevance while maintaining modular simplicity that doesn't excessively increase overall device complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A spun elastomer scaffold acts as an intermediary structure between the culture medium and the cells. This scaffold provides the necessary mechanical support and architectural framework to replicate layered tissue structure, while allowing cells to be seeded and exposed to controlled hemodynamic stresses, thereby achieving physiological relevance without requiring complex synthetic systems

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If animal models are used for therapeutic evaluation, then the physiological conditions are more realistic, but ethical concerns arise and approximately 90% of therapeutics fail in subsequent human trials

Engineering Contradiction:
Improvepredictive accuracyVSAvoidethical concerns
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The device creates an in vitro copy of the in vivo human physiological environment using human cells cultured on spun elastomer scaffolds under controlled hemodynamic conditions. This copying approach provides a more ethically acceptable alternative to animal models while maintaining high predictive accuracy for human therapeutic responses, as the system directly replicates human tissue architecture and physiological stresses

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The system enables precise control and adjustment of physiological parameters such as shear stress, pressure, and flow rate to match in vivo human conditions. By dynamically adjusting these parameters, the device achieves high predictive accuracy for human therapeutic responses without requiring animal subjects, thereby eliminating ethical concerns while maintaining reliability

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If current proposed solutions are used, then some specific functions are addressed, but they fail to provide comprehensive interfacial function configurability for perfusion and cannot mimic layered tissue architecture

Engineering Contradiction:
Improveinterfacial function configurabilityVSAvoidphysiological suitability
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The spun elastomer scaffold system serves multiple functions simultaneously: it provides structural support for layered tissue architecture, enables cell seeding and attachment, allows configurable perfusion through its porous structure, and facilitates exposure to hemodynamic stresses. This multi-functionality achieves comprehensive interfacial function configurability while maintaining high physiological suitability for therapeutic evaluation

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The spun elastomer scaffold utilizes a porous structure that naturally allows fluid perfusion while providing mechanical support and cell attachment sites. This porous architecture enables configurable flow patterns and interfacial functions without requiring complex additional components, thereby achieving both adaptability and physiological suitability through the inherent properties of the porous material

Inventive Principle:
Principle #31Porous materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The apparatus effectively simulates in vivo conditions, enabling more accurate evaluation of therapeutics and disease modeling, reducing the risk of therapeutic failures in human trials by replicating essential physiological stresses and tissue architecture.

Implementation Method 1

vascular cells cultured in the absence of appropriate hemodynamic stresses, such as shear, pressure, and stretch

Methodology Applied
Scientific EffectShear stress: Shear Stress

Implementation Method 2

appropriate hemodynamic stresses, such as shear, pressure, and stretch

Methodology Applied
Scientific EffectPressure: Pressure Increase

Implementation Method 3

the pump is configured to flow fluid in a circuit through the tubing and each cassette

Methodology Applied
Scientific EffectFluid flow:

Data Source

PatentUS11965876B1Biomimetic interface device and methods of using the same
Publication Date: 2024.04.23 BUDHWANI KARIM I
  • US11965876B1 patent drawing
  • US11965876B1 patent drawing
  • US11965876B1 patent drawing

AI summary

The present disclosure generally pertains to a biomimetic apparatus configured to simulate physiological conditions by, in part, providing for both barrier and transport interfaces. The presently disclosed apparatus may be used to: test therapeutics for different diseases; to study transport; form a substrate for any organ tissue with a barrier and/or transport function; provide a closed loop assembly for fluid flow; mimic underlying and enveloped tissue; and model external environmental conditions.